Skip to content

Interpersonal Psychotherapy in Adolescents With Polycystic Ovary Syndrome

Interpersonal Psychotherapy in Adolescents With Polycystic Ovary Syndrome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06056453
Acronym
IPAP
Enrollment
30
Registered
2023-09-28
Start date
2021-09-20
Completion date
2023-07-14
Last updated
2023-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interpersonal Psychotherapy, Polycystic Ovary Syndrome

Brief summary

The main purpose of this study is to find out whether taking part in a group-based interpersonal psychotherapy (IPT) program designed to improve mood and lessen stress in girls with PCOS will improve depression, unhealthy eating behaviors, weight, and insulin resistance.

Interventions

BEHAVIORALInterpersonal Psychotherapy

IPT group-virtual

Sponsors

American Psychological Association (APA)
CollaboratorOTHER
University of Colorado, Denver
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
12 Years to 17 Years
Healthy volunteers
Yes

Inclusion criteria

* Diagnosed with PCOS duration \> 3 months * 12-17 years old * BMI \> 75th percentile * CESD \> 16

Exclusion criteria

* Weekly or bi-weekly therapy with licensed behavioral health provider * Inability to speak, read, or write in English (teen) * Major medical conditions * HbA1c \> 7.0% * Hormonal contraception \< 3 months * Metformin \< 3 months * Antidepressants/psychotropic medications \< 4 weeks

Design outcomes

Primary

MeasureTime frameDescription
Center for Epidemiologic Studies-Depression ScaleBaselineDepression symptoms will be assessed by the Center for Epidemiologic Studies-Depression Scale. Scores range from 1 to 4. The scoring of positive items is reversed. Possible range of scores is zero to 60, with the higher scores indicating the presence of more symptomatology.

Secondary

MeasureTime frameDescription
Loss-of-Control Eating Disorder QuestionnaireBaseline, 6-Week Follow-Up Assessment, 6-Month Follow-Up AssessmentLoss-of-control eating will be assessed via the 19-item Loss-of-Control Eating Disorder Questionnaire (LOC-ED-Q), which shows sound psychometric properties in adolescents using Yes/No.
Reward Based Eating Drive ScaleBaseline, 6-Week Follow-Up Assessment, 6-Month Follow-Up AssessmentReward based eating will be assessed by the Reward Based Eating Drive Scale. This is a self-report questionnaire which assesses reward-based eating that shows sound psychometric properties. The total score is summed at the end; a higher total is indicative of reward-based eating.
BMIBaseline, 6-Week Follow-Up Assessment, 6-Month Follow-Up AssessmentFasting BMI (kg/m2) will be derived from measured height in triplicate by stadiometer and measured fasting weight by calibrated digital scale. BMI z-score and BMI %ile will be computed to determine eligibility (BMI ≥75th percentile).
Emotional Eating Scale Adapted for ChildrenBaseline, 6-Week Follow-Up Assessment, 6-Month Follow-Up AssessmentDisordered eating will be assessed by the Emotional Eating Scale Adapted for Children. The scale has been adapted for children and assesses eating in response to negative affect, such as feeling sad or irritated. The scale ranges from I have no desire to eat to I have a very strong desire to eat and averages how many days a week the participant eats based on that feeling.
DysglycemiaBaseline, 6-Week Follow-Up Assessment, 6-Month Follow-Up AssessmentBlood will be sampled via a venipuncture procedure following a 10-hour overnight fast to measure fasting insulin. Insulin resistance will be estimated from fasting insulin and glucose with the homeostatic model assessment of insulin resistance (HOMA-IR).
DyslipidemiaBaseline, 6-Week Follow-Up Assessment, 6-Month Follow-Up AssessmentBlood will be sampled via a venipuncture procedure following a 10-hour overnight fast to measure dyslipidemia. Insulin resistance will be estimated from fasting insulin and glucose with the homeostatic model assessment of insulin resistance (HOMA-IR).
Insulin ResistanceBaseline, 6-Week Follow-Up Assessment, 6-Month Follow-Up AssessmentBlood will be sampled via a venipuncture procedure following a 10-hour overnight fast to measure fasting insulin. Insulin resistance will be estimated from fasting insulin and glucose with the homeostatic model assessment of insulin resistance (HOMA-IR).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026